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The annual meeting of the European Association of Echocardiography (EuroEcho-Imaging) was held in Istanbul, Turkey. In the present paper,
we present a summary of the ‘Highlights’ session.
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Introduction
The second annual scientific meeting of the European Association of
Cardiovascular Imaging (EACVI), EuroEcho-Imaging 2013, was held
in Istanbul, Turkey. The meeting was marked by two major events:
(i) the celebration of a decade of success of our association in the
field of CVI and (ii) the ratification of the new constitution of the
unified EACVI structure that integrates the main non-invasive CVI
stakeholders. The main themes were heart failure and imaging in
interventional cardiology. The meeting was a great success with a
record number of participants (3234 delegates) and over 1400
abstracts submitted. The last day of the meeting, the ‘Highlights’
session wrapped up the event with a summary of the most relevant
abstracts presented throughout the congress. A short report of
this session is presented below.
Heart failure
Muraru et al. assessed the mitral valve morphologyof 32 patients with
hypertrophic cardiomyopathy (HCM) using a semi-automated mitral
valve analysis by 3D-transthoracic echocardiography (3D-TTE).1
When compared with controls, patients with HCM had significant
larger mitral leaflet and annulus areas and greater posterior leaflet/
mitral annulus area ratio. 3D-TTE posterior leaflet area (.4.64 cm2)
enabled an excellent discrimination of patients with HCM, and was
correlated with LV remodelling and dynamic obstruction. Takotsubo
cardiomyopathy (TTC) is an important differential diagnosis of acute
coronary syndrome.2 Serial 2D speckle tracking echocardiography
was performed in 40 patients with typical pattern of TTC. At admis-
sion, a circular impairment in regional strain was reported. Of note,
functional recovery was asymmetrical at Day 5 and complete at
1-month follow-up. In LV non-compaction cardiomyopathy
(NCC), heart failure is the most common clinical presentation and
the main predictor of outcome.3 Mansencal et al. evaluated the rela-
tionship between the degree and extent of LV NCC and regional
myocardial function using 2D speckle tracking imaging. Thirty
patients with NCC were compared with 30 patients with dilated car-
diomyopathy (DCM). NCC was present in 48 segments (10%),
mainly localized in the apical region and the lateral wall. Borderline
C was observed in 80 (16.6%) segments and normal C was present
in 330 (68.7%) segments. Akinesia (19.3%) and hypokinesia (68%)
were more frequent in C segments than in NC or borderline seg-
ments. Basal and median strain values were similar in both groups.
Apical strain values were higher in NCC than that in DCM with a sig-
nificant apical/basal strain gradient (P, 0.05). Many of the life-saving
cancer therapies can have significant and serious cardiovascular side
effects. During the meeting, several reports focused on the late
cardiac effects of anticancer treatments. In 80 patients treated with
chemotherapy between 1995 and 2011, Roussin et al. compared
standard evaluation of LV systolic function (LV ejection fraction) to
2D speckle tracking myocardial deformation (global longitudinal
strain, GLS).4 GLS was lower (213.9+3.6 vs. 219.2+ 1.3%,
P, 0.01) in cancer survivors than in controls despite preserved LV
ejection fraction.4 Therefore, GLS analysis is enabled to accurately
identify subclinical LV dysfunction. The long-term clinical and prog-
nostic significance of these findings requires further investigation.
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In the setting of LV dyssynchrony, although echocardiography has
gained progressive interest, its clinical usefulness remains controver-
sial.5– 7 In heart failure patients eligible for cardiac resynchronization
therapy (CRT), predicting the occurrence of ventricular arrhyth-
mias is of importance. Hasselberg et al. studied 73 patients receiving
CRT with 2D speckle tracking imaging. Ten (14%) of these patients
developed sustained ventricular tachycardia/ventricular fibrillation
during follow-up. While LV ejection fraction was not a marker of
ventricular arrhythmia, GLS was. Indeed, LV ejection was similar
between groups whereas GLS was more reduced in patients with ar-
rhythmia. The assessment of GLS in heart failure candidate for CRT
may help identify those who may benefit from an implantable cardi-
overter defibrillator. In heart failure, the presence of mitral regurgi-
tation (MR) plays a central role in determining pulmonary flow
overload and pulmonary hypertension.8 The determinants of right
ventricle (RV) adaptation during exercise was assessed in 44 patients
with heart failure and preserved LVejection fraction. MR severity was
strongly related to the functional response of the RV during maximal
exercise and to ventilatory inefficiency (steeper VE/VCO2 slope).
Right ventricular (RV) dysfunction and failure basically affect the clin-
ical course in heart failure syndrome. In 459 patients with systolic
heart failure, Bandera et al. showed that a ,0.36 TAPSE/PASP ratio
(tricuspid annular systolic excursion/pulmonary arterial systolic pres-
sure) could serve as to identify a subset of heart failure patients at
higher risk.9
Valvular heart disease
The outstanding role of multi-imaging modalities in the management
and risk stratification of patients with valvular heart disease continues
to gain interest. The vast majority of abstracts submitted under the
topic of valvular heart disease investigated aortic stenosis (AS).
In this regard, Tsang et al. reported the outcome results of 106 medically
managed patients with symptomatic AS and not suitable for aortic
valve replacement (AVR).10 As expected, they found a high mortality
rate of 56% during a mean follow-up of 1.8 years. Using various multi-
variable models, they identified that the best echocardiographic pre-
dictors of mortality were LV ejection fraction, four-chamber GLS,
mitral E/e′ ratio and LA volume. In addition, although the Society of
Thoracic Surgeons score was an excellent predictor of mortality,
the combination of echocardiographic parameters was statistically
better. A specifically dedicated oral session on LV myocardial strain
in patients with AS was held during the meeting. Carstensen et al.
compared the LV geometry and function of three groups of AS:
asymptomatic patients with preserved LV ejection fraction (n ¼ 105,
control group), symptomatic patients with preserved LV ejection
fraction (n ¼ 72), and symptomatic patients with depressed LV ejec-
tion fraction (n ¼ 69).11 Of interest, when compared with control
group, patients with impaired LV ejection fraction exhibit significantly
lower LV myocardial longitudinal, circumferential, and radial strains.
However, despite similar LV geometry, mass, and LV circumferential
and radial strains, patients with preserved LV ejection fraction had a
significant lower LV longitudinal strain than the control group. This
was particularly highlighted in LV basal segments. Similarly, in 55
asymptomatic patients with moderate to severe AS and preserved
LV ejection fraction, Dulgheru et al. reported that maximal exercise
capacity was mainly determined by basal LV myocardial longitudinal
strain on multivariable analysis.12 In contrast, both mid- and apical
LV longitudinal strains were not significantly associated with peak
oxygen uptake. Using exercise stress echocardiography, Federspiel
et al. have shown that exercise-induced changes in mean transaortic
pressure were highly predictive of combined cardiovascular event
(only including death and hospitalization for worsening heart
failure) in 195 asymptomatic patients with preservedLVejection frac-
tion and moderate or above AS.13 Other predictors of events were
an LA surface of .25 cm2 and previous myocardial infarction. The
so-called paradoxical low-flow low-gradient (LFLG) entity of
severe AS was extensively discussed during the meeting. Fabris
et al. studied a population of 170 severe AS with a mean pressure gra-
dient of ≤30 mmHg and LV ejection fraction of ≥55%.14 These
patients depicted the typical pattern of ‘paradoxical’ LFLG severe
AS, i.e. small LV cavity, high degree of LV concentric hypertrophy,
and high valvulo-arterial impedance. Furthermore, severe symptoms
(NYHA ≥ III), atrial fibrillation, and no AVR during the follow-up
were the main determinants of mortality. In a retrospective multicen-
tre study, Sato et al.have identifiedLVglobal longitudinal strain,17%
as a major predictor of cardiovascular event in ‘paradoxical’ LFLG
AS.15 Following transcatheter aortic valve implantation (TAVI), all
patients included in the study of Knebel et al. exhibited significantly
better LV longitudinal function than before intervention.16 Never-
theless, this improvement was more pronounced in ‘paradoxical’
LFLF severe AS group. Left atrial (LA) function plays a crucial role
in patients with MR. The peak systolic longitudinal strain of the LA
was quantified using 2D speckle tracking in 276 patients. Cardiovas-
cular events were found in 108 patients and peak atrial longitudinal
strain ,15% was associated with markedly reduced event-free sur-
vival.17 Kozdag et al. aimed to identify the impact of the presence of
tricuspid regurgitation (TR) on 30-day readmission for heart
failure.18 They studied a large cohort of 706 patients hospitalized
for worsening of HF. A moderate to severe TR was reported in
58% of the 131 patients with 30-day re-admission for heart failure.
In multivariable analysis, TR proved to be a significant independent
predictor of early readmission in patients with heart failure.
3-Dimensionnal echocardiography
Using 2D echocardiography, the proximal isovelocity surface area
(PISA) is assumed to be hemispherical. The calculated flow rate
across the leaking mitral valve (Qmr) varies with the selected aliasing
velocity. In addition, the optimal range of velocities is shifted upward
with increasing Qmr. Brugger et al. sought to demonstrate that Qmr
derived from 3D PISA was independent of the Nyquist limit, because
the PISA surface was directly measured. In patients with MR referred
for transoesophageal echocardiography (TOE), the PISA with clear
aliasing boundaries were extracted as slices after 3D reconstruction
using customized software. They showed that using Nyquist limits of
30.8 and 41.1 cm/s, Qmr as measured by 3D PISAwas stable; this sta-
bility was not influenced by the amount of Qmr.19 Accurate assess-
ment of prosthetic valve internal diameter (ID) is essential for
effective and safe treatment. Condemi et al. performed 2332 2D/
3D TOE in vitro measurements on 53 bioprosthetic valves. 2D Echo
ID measurements were made in two orthogonal planes at the level
of the sewing ring and similar 3D measurements were generated
from multi-plane reconstructions. They were compared with both
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the manufacturer supplied valve ID (M.ID) and the True ID (T.ID)
measured with Hegar dilators. The authors showed that T.ID was sig-
nificantly smaller than M.ID, and this might lead to a wrong choice of
implanted valve.20 Veronesi et al. developed novel custom software
to trace and measure tricuspid valve annulus (TVA). When compared
with controls, TVA was larger in patients with pulmonary hyperten-
sion. The tricuspid annulus was also more circular and with less lon-
gitudinal displacement. Changes in annular remodelling were not
uniform. The anterior and posterior segments were enlarged, while
the septal remained unchanged. This novel software revealed that
pulmonary hypertension affects size, shape, and function of the
TVA, suggesting that 3D analysis may be useful for evaluation of dif-
ferent RV disease states.21 Brugger et al. compared the regurgitant
volume (RVol) in 37 patients with chronic MR using TOE and
cardiac magnetic resonance (CMR) imaging. For each patient, all
PISA visible during systole were 3D reconstructed using customized
software. 3D-PISA total RVol was directly related to CMR-RVol.
Patients with severe MR according to CMR-RVol ≥60 mL were all
correctly classified as severe by 3D-PISA.22 Muraru et al. evaluated
the reference values for 3D LV volumes and function parameters
comparing vendor with a vendor-independent DICOM-based soft-
ware in 235 healthy volunteers. Despite the differences in LV para-
meters obtained with both software were statistically significant,
Bland–Altman analysis showed a clinically irrelevant bias and reason-
able limits of agreement for all measurements with both software.23
Shivalkar et al. studied 146 consecutive patients with an indication
for dobutamine stress echocardiography (DSE) with 2D echo, 3D-
triplane and full volume acquisitions with and without myocardial
contrast (MCE) given at rest and peak stress for LV opacification.
They showed that agreement between 2D and 3D stress echo was
poor for abnormal vs. normal stress tests. Furthermore, they were
able to demonstrate that early revascularization as well as major
cardiovascular events at 36 months of follow-up were predicted
accurately by 3D-DSE but not by 2D-DSE.24 3D TOE allows a com-
prehensive evaluation of aortic atheroma. Caminati et al. aimed to
develop an automated method to allow reconstruction of the des-
cending aorta from contiguous 3D TOE images for total plaque
burden quantification. Algorithm performance was first tested on
phantom images. The results on the validation datasets confirmed
the feasibility and accuracy of the proposed method and its potential
clinical applicability, with increased field-of-view compared with mul-
tiple single acquisitions and improved spatial resolution in the over-
lapped areas.25 Debonnaire et al. assessed the characteristics,
determinants, and relation between secondary MR severity and
mitral valve leaflet remodelling (enlargement) in 24 patients with
grade 1–2 MR, 30 patients with grade 3–4 MR, and 22 control sub-
jects with normal structural and functional MV. They demonstrated
that the degree and extent of MV leaflet remodelling was independ-
ently associated with MR severity.26
CMR imaging
CMR imaging remains the clinical reference for right ventricular
volume and functionassessment. The analysis of RV volumes requires
expertise. Grapsa et al. demonstrated that after the analysis of 120
scansCMRand3D echocardiography have comparable andexcellent
inter- and intra-observer agreement, but that the learning curve is
better for CMR, likely due to the clearer endocardial border
definition.27
The CMR response to echo speckle tracking is called tissue or
feature tracking. Importantly, this technique, unlike tagging, does
not require additional image acquisition, as standard cine images
canbeused.Orwatetal.demonstratedthatmyocardial strainmeasured
by CMR related to functional status (NYHA class, P ¼ 0.0005), object-
ive exercise capacity (peak oxygen uptake, P ¼ 0.02), and neurohor-
monal levels (NT-pro-BNP, P ¼ 0.007) in adults with congenitally
corrected transposition of the great arteries independently of global
systemic strain measured by echo and CMR LV ejection fraction.28
Franzoso et al. compared left and right atrial size and function in ar-
terial switch and atrial switch repair for transposition of the great ar-
teries using CMR.29 The atrial size and function in patients after the
atrial switch procedure is abnormal compared with patients after
the arterial repair and healthy controls. The atrial reservoir and
pump function are reduced, the conduit function, however, was
increased. Impaired atrial function may be an important determinant
of RV failure. Left atrial volumes measured by 2D echocardiography
and CMR were compared by Axelsson et al. in patients with HCM.30
There is a systematic underestimation of LA volumes with many 2D
echocardiography methods compared with CMR in healthy controls
which, interestingly, was not observed in HCM and the authors
speculated whether this was related to different LA geometry in
HCM. CMR is also an elegant technique to diagnose myocarditis non-
invasively through oedema-sensitive and contrast-based techniques
demonstrating myocardial damage different to the one seen follow-
ing myocardial infarction. Halmai et al.demonstrated reduced systolic
deformation indices (3D speckle tracking) in those segments corre-
sponding to myocardial involvement on CMR despite preserved LV
ejection fraction.31 3D speckle tracking may thus be an alternative
technique to identify abnormalities due to myocarditis if CMR is
not feasible. Marques et al. found a strong relationship between the
extent of late gadolinium enhancement and NT-proBNP (r ¼ 0.74,
P ¼ 0.003) despite mostly preserved LV ejection fraction and con-
cluded that this underlines the role of CMR for providing an in vivo
histology.32
A prospective cohort study presented by Poyhonen et al.33 sug-
gested that the extent of late gadoliniumenhancement and segmental
wall motion abnormalities on CMR could predict adverse outcomes
in non-ischaemic cardiomyopathy. Coronary MR angiography has
not yet been established in clinical routine except for the assessment
of anomalous origin of coronary arteries. Coronary CT angiography
for the assessment of severity of coronary stenosis may be limited by
coronary calcium, but Iwaki et al. now showed that image quality of
MR angiography can also be affected by calcifications.34 A cost-
effectiveness study presented by Gosh Dastidar et al. suggested a po-
tential cost saving of £285 per patient using stress imaging (stress
echocardiography or stress CMR) compared with fractional flow
reserve guided approaches to manage primary PCI patients with ST
elevation myocardial infarction and additional non-culprit lesions.35
Congenital heart disease
The congenital heart programme at EuroEcho-Imaging 2013 benefit-
ed from a strong scientific programme and a large number of
abstracts covering the full range of our specialty from foetal
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echocardiography through childhood to adult congenital heart
disease. There was strong representation from all imaging sections,
often within the one abstract. The RV was a pre-eminent subject
and for this reason will be covered by this highlight report. In new
borns with hypoplastic left heart syndrome (HLHS), Bellsham-Revell
et al. used speckle tracking echo (STE) to measure tricuspid annular
descent (TAD) as a measure of RV systemic ventricular function after
Norwood 1 palliation.36 There was no significant difference in 30-day
mortality according to LV morphology, ascending aorta size or
TAD%. A lower TAD% was seen in those with subjectively impaired
RV function (17.7% vs. 13.6%, P ¼ 0.001) and more than mild TR was
a risk factor for death (P ¼ 0.002).
Menting et al. investigated the differences in RV deformation in
adult congenital patients .30 years after repair of tetralogy of
Fallot (ToF) or atrial septal defect (ASD).37 RV lateral wall global
strain and the strain of all three RV segments separately were signifi-
cantly lower in ToF and ASD patients than in healthy controls. Strain
rate of the RV apical segment was lower in ToF and ASD patients than
in controls (P, 0.001, P ¼ 0.03). LV global strain was reduced in ToF
patients (P, 0.001) but not in ASD. Finally, RVglobal strain was posi-
tively correlated with LV global strain in both patients groups, which
suggests ventricular–ventricular interaction.
Assessment of systemic RV function is key in the follow-up of
patients after the atrial switch procedure for transposition of the
great arteries (TGA). Many centres consider cardiac CMR as the
gold standard for RV assessment. Lypcynska et al. used 2D speckle
tracking echo to assess of RV function in this patient group and
reported a cut-off strain value to differentiate normal and sub-normal
RV systolic function.38 They examined 40 adult patients (mean age
25.6+5 years; 33 after Senning, 7 after Mustard operation) with
77% NYHA class I, 20% in NHYA class II, and 3% in NHYA class III.
There was a linear correlation between GLS and CMR RV ejection
fraction values (r ¼ 0.4, P ¼ 0.01) and between RV fractional area
change and CMR RV ejection fraction (r ¼ 0.41, P ¼ 0.008). There
was no correlation between RV s′, TAPSE or RV dP/dT and CMR
RV ejection fraction. Importantly, only 1 out of 19 patients with
GLS , -14.2% had CMR RV ejection fraction ,45%. A GLS cut-off
value of 214.2% predicted the CMR RV ejection fraction of ≥45%
with 90% specificity and 83% sensitivity and a positive predictive of
96%.
In children following the arterial switch operation (ASO) for TGA,
Marinov et al. reported that up to 40% of such children might have
perfusion defects on scintigraphy undetected on angiography.39
Using GLS they demonstrated a significant difference for both the
RV and LV in this patient group compared with controls. Further-
more, GLS was able to detect abnormality even in those with a
normal ejection fraction or TAPSE.
New techniques also featured prominently in the CHD sessions.
Two groups compared RV volumes obtained by knowledge-based
reconstruction (KBR). Grosse-Wortmann et al. applied KBR to
CMR datasets and compared with RV volumes obtained by conven-
tional slice plane summation.40 In two separate studies from the same
group, Laser et al.41 and Horst et al.42 aimed to validate KBR volumes
obtained from CMR and 3D echo datasets against the gold standard
of CMR disc summation. In all three papers, there was good agree-
ment in the volumes, intra- and inter-observer variability, coupled
with a short processing time. They suggest that KBR may reduce
the time to estimate RV volume and minimize the need for CMR in
this patient group.
Nuclear cardiology and cardiac
computed tomography
Saraste et al. examined whether short-term spinal cord stimulation
(SCS) therapy improves myocardial flow reserve (MFR) and
reduces dobutamine-induced myocardial wall motion abnormalities
in patients with myocardial ischaemia.43 MFR was assessed by posi-
tron emission tomography (PET) and [15O]H2O during rest and ad-
enosine stress. The study showed that short-term SCS treatment
improvedmyocardial flowreserve and reduced dobutamine-induced
wall motion abnormalities in patients with ischaemic heart disease
and severe angina pectoris, indicating that the treatment had
anti-ischaemic effects. Kisko et al. evaluated retrospectively the prog-
nostic value of gated SPECT (single photon emission computed tom-
ography) MPI (myocardial perfusion imaging) in 170 patients with
non-stenotic coronary lesions (NSCL) in coronary angiography.44
Over a 2-year follow-up, 11% of the patients with abnormal
SPECT MPI had major coronary events when compared with 3.2%
in those with normal SPECT MPI (P, 0.01). The authors recom-
mend gated SPECT MPI in all patients with NSCL. Flori et al. validated
Thallium-201 stress-rest ECG-gated SPECT, using a new cadmium-
zinc-telluride camera, vs. usual echocardiographic parameters for
LV global and regional function analysis.45 Correlation between the
two methods was good for end-diastolic volume, end-systolic
volume, and LV ejection fraction. Correlation was also good regard-
ing regional function. Sunbul et al. using PET evaluated the association
of right to LV fluoro-D-glucose uptake ratio (RV/LV FDG-PET) with
RV function in 35 patients with chronic thromboembolic pulmonary
hypertension.46 TAPSE was used as a measure of RV function. It was
found that patients with higher RV/LV FDG PET had lower TAPSE,
and therefore decreased RV function. Andreini et al. assessed the
diagnostic performance of multidetector computed tomography
coronary angiography (MDCT-CA) for coronary artery evaluation
in 325 patients, who also underwent invasive coronary angiography
before TAVI.47 MDCT-CAwas performed using the same acquisition
and dataset employed to standard MDCT aortic annulus evaluation.
MDCT-CA showed high sensitivity, specificity, positive predictive
value, negative predictive value, and accuracy for detecting ≥50%
coronary artery stenosis. The authors recommend routine use of
MDCT-CA to rule out significant coronary artery stenosis in patients
referred for TAVI. Dobson et al. assessed the incidence of normal,
mild (,50% stenosis), and significant (.50% stenosis) coronary
artery disease (CAD) on computed tomography coronary angiog-
raphy (CTCA) in a cohort of 148 patients to establish the predictive
value of single vs. all three risk factors (diabetes, smoking, hyperlipid-
aemia).48 They also assessed the incidence of CAD based on ethni-
city, sex, and typicality of the chest pain. They showed that patients
with three risk factors had a much higher incidence of CAD than
patients with a single risk factor. The authors pointed out that
NICE guidelines need clarification on whether they intended ‘high
risk’ to mean a single risk factor or three risk factors. In addition,
typicality of the chest pain was a good predictor of CAD. Cai et al.
retrospectively reviewed 213 patients with a moderate or high risk
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of CAD based on NICE guidelines CAD score.49 CTCA was per-
formed in 107, DSE in 67, and myocardial perfusion scintigraphy in
39 patients. Functional tests led to similar percentage of revasulariza-
tions compared with CTCA. The authors concluded that CTCA
should be considered as an effective alternative to functional tests
in patients with higher pre-test probability of CAD, in hospitals
with limited access to functional tests. Barreiro Perez et al. demon-
strated that a high percentage of inappropriate indications (according
to appropriate use guidelines) for CTCA were noted in a sample of
246 patients, who underwent 64-slice CTCA between 2006 and
2012.50 CAD was ruled out significantly more when the indication
was appropriate. Patients with inappropriate indication had a
greater number of events in the follow-up. Mushtaq et al. investigated
the long-term prognostic value of MDCT-CA in a large population of
698 coronary artery bypass graft (CABG) patients and mean follow-
up of 73.5+ 14 months.51 Patients were classified by unprotected
coronary territory (UCTs) or the coronary artery protection
score (CAPS). It was shown that MDCT-CA appears to be a promis-
ing tool for long-term risk stratification of CABG patients. Particular-
ly, UCTs performed better than CAPS score for assessment of
prognosis. Sunman et al. investigated the diagnostic accuracy of dual-
source MDCT-CA in elderly patients in comparison to younger
patients.52 MDCT-CA results were compared with the results of
conventional coronary angiography. A total number of 181 patients
were examined with MDCT-CA. Among them, 93 patients were
older than 65 years of age 88 were younger. The results showed
that sensitivity and positive predictive values were slightly lower for
older patients compared with younger. Specificity and negative pre-
dictive values were high and similar for both groups.
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